CTLA4 and Miyoshi myopathy: Differently from our previous report showing that higher baseline IL-6 levels in MM patients treated with anti CTLA-4 antibodies were independently related to a worse survival rate in females [43], in this case series a sex-related interaction of IL-6 levels and activity or efficacy of ICIs was not found.